Search

Author/Creator Bautista, Guiomar

1. A paired trial comparing mononuclear cell collection in two machines for further inactivation through an inline or offline extracorporeal photopheresis procedure. Issue 1 (4th October 2018)

Authors:
Bueno, José‐Luis; Alonso, Rosalía; Gonzalez‐Santillana, Clara; Naya, Daniel; Romera, Irene; Alarcón, Ana; Aguilar, Myriam; Bautista, Guiomar; Duarte, Rafael; Ussetti, Piedad; Cabrera, José Rafael
Journal:
Transfusion
Issue:
Volume 59:Issue 1(2019)
Page Start:
340
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program. Issue 5 (30th March 2015)

Authors:
García‐Gutiérrez, Valentín; Martinez‐Trillos, Alejandra; Lopez Lorenzo, Jose Luis; Bautista, Guiomar; Martin Mateos, Maria Luisa; Alvarez‐Larrán, Alberto; Iglesias Pérez, Ana; Romo Collado, Andrés; Fernandez, Angeles; Portero, Angeles; Cuevas, Beatriz; Ruiz, Concepción; Romero, Esperanza; Ortega,...
Journal:
American journal of hematology
Issue:
Volume 90:Issue 5(2015:May)
Page Start:
429
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group. Issue 1 (15th July 2020)

Authors:
Solano, Carlos; Vázquez, Lourdes; Giménez, Estela; de la Cámara, Rafael; Albert, Eliseo; Rovira, Montserrat; Espigado, Ildefonso; Calvo, Carmen M.; López‐Jiménez, Javier; Suárez‐Lledó, María; Chinea, Anabella; Esquirol, Albert; Pérez, Ariadna; Bermúdez, Aránzazu; Saldaña, Raquel; Heras, Inmaculad...
Journal:
American journal of transplantation
Issue:
Volume 21:Issue 1(2021)
Page Start:
258
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?. Issue 11 (27th August 2014)

Authors:
García‐Gutiérrez, Valentin; Puerta, Jose Manuel; Maestro, Begoña; Casado Montero, Luis Felipe; Muriel, Alfonso; Molina Hurtado, Jose Ramon; Perez‐Encinas, Manuel; Moreno Romero, Maria Victoria; Suñol, Pere Barba; Sola Garcia, Ricardo; De Paz, Raquel; Ramirez Sanchez, Maria Jose; Osorio, Santiago;...
Journal:
American journal of hematology
Issue:
Volume 89:Issue 11(2014:Nov.)
Page Start:
E206
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Paroxysmal nocturnal hemoglobinuria: a single Spanish center's experience over the last 40 yr. (13th May 2014)

Authors:
Muñoz‐Linares, Cristina; Ojeda, Emilio; Forés, Rafael; Pastrana, Miguel; Cabero, Martín; Morillo, Daniel; Bautista, Guiomar; Baños, Isolina; Monteserín, Carmen; Bravo, Pilar; Jaro, Esther; Cedena, Teresa; Steegmann, Juan Luis; Villegas, Ana; Cabrera, José Rafael
Journal:
European journal of haematology
Issue:
Volume 93:Number 4(2014:Oct.)
Page Start:
309
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Switching to second‐generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib‐treated patients with chronic myeloid leukemia with more than 10% of BCR‐ABL/ABL ratio at 3 months. (10th March 2015)

Authors:
Casado, Luis‐Felipe; García‐Gutiérrez, José‐Valentín; Massagué, Isabel; Giraldo, Pilar; Pérez‐Encinas, Manuel; de Paz, Raquel; Martínez‐López, Joaquín; Bautista, Guiomar; Osorio, Santiago; Requena, María‐José; Palomera, Luis; Peñarrubia, María‐Jesús; Calle, Carmen; Hernández‐Rivas, José‐Ángel; Bu...
Journal:
Cancer medicine
Issue:
Volume 4:Number 7(2015:Jul.)
Page Start:
995
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia. (October 2022)

Authors:
Ortí, Guillermo; García-Gutiérrez, Valentín; Bautista, Guiomar; Ferrer-Marín, Francisca; Vallansot, Rolando; Xicoy, Blanca; Sánchez, Àngela; Simon, Isabel; Triguero, Ana; Sierra, Magdalena; Casado, Luis Felipe
Journal:
Leukemia research
Issue:
Volume 121(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗